Allogene 治療公司
US ˙ NasdaqGS ˙ US0197701065

SecurityALLO / Allogene Therapeutics, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership207,518 shares
Latest Disclosed Value $ 284,300
Alliancebernstein L.p. reports 30.01% decrease in ownership of ALLO / Allogene Therapeutics, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 207,518 shares of Allogene Therapeutics, Inc. (US:ALLO) valued at $506,344 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 296,498 shares of Allogene Therapeutics, Inc.. This represents a change in shares of -30.01% during the quarter. The current value of the position is $423,337 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 207,518 -88,980 -30.01 284 -30.05 0.0001
2026-02-17 2025-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 296,498 0 0.00 406 10.63 0.0001
2025-11-14 2025-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 296,498 0 0.00 368 9.55 0.0001
2025-08-14 2025-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 296,498 108,090 57.37 335 21.82 0.0001
2025-05-15 2025-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 188,408 -21,670 -10.32 275 -38.48 0.0001
2025-02-12 2024-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 210,078 0 0.00 447 -23.98 0.0002
2024-11-14 2024-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 210,078 0 0.00 588 20.25 0.0002
2024-08-14 2024-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 210,078 55,270 35.70 489 -29.23 0.0002
2024-05-14 2024-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 154,808 0 0.00 692 39.31 0.0002
2024-02-14 2023-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 154,808 10,090 6.97 497 8.30 0.0002
2023-11-14 2023-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 144,718 -18,630 -11.41 459 -43.53 0.0002
2023-08-15 2023-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 163,348 62,440 61.88 812 62.85 0.0003
2023-05-15 2023-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 100,908 14,800 17.19 498 -7.95 0.0002
2023-02-15 2022-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 86,108 -411 -0.48 542 -42.08 0.0002
2022-11-15 2022-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 86,519 -542,988 -86.26 934 -86.98 0.0005
2022-08-15 2022-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 629,507 538,699 593.23 7,176 767.71 0.0033
2022-05-13 2022-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 90,808 100 0.11 827 -38.88 0.0003
2022-02-14 2021-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 90,708 -3,126,577 -97.18 1,353 -98.36 0.0005
2021-11-10 2021-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 3,217,285 50,655 1.60 82,684 0.12 0.0326
2021-07-30 2021-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 3,166,630 625,071 24.59 82,586 -7.95 0.0332
2021-05-06 2021-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 2,541,559 -47,299 -1.83 89,717 37.30 0.0393
2021-02-08 2020-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 2,588,858 654,713 33.85 65,343 -10.41 0.0308
2020-11-12 2020-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 1,934,145 231,025 13.56 72,937 0.01 0.0393
2020-08-13 2020-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 1,703,120 -273,604 -13.84 72,928 89.78 0.0429
2020-05-14 2020-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 1,976,724 200,421 11.28 38,428 -16.73 0.0275
2020-02-18 2019-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 1,776,303 162,594 10.08 46,148 4.92 0.0262
2019-11-14 2019-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 1,613,709 84,060 5.50 43,982 7.09 0.0274
2019-08-14 2019-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 1,529,649 164,642 12.06 41,071 4.08 0.0255
2019-05-14 2019-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 1,365,007 79,580 6.19 39,462 14.00 0.0257
2019-02-13 2018-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 1,285,427 1,285,427 34,617 0.0257
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.